ADVANCED DEVELOPMENT OF PATHOGEN INACTIVATION TECHNOLOGY USING S-303 FOR RED BLOOD CELL COMPONENTS

$1,401,000FY2010Department of the ArmyDOD

Cerus Corporation, Concord CA

Investigators